What is Oaktree Acquisition Corp. III Life Sciences's market cap?

Oaktree Acquisition Corp. III Life Sciences (OACC) has a market capitalization of $263.0M and trades on XNAS.

Who are Oaktree Acquisition Corp. III Life Sciences's competitors?

Oaktree Acquisition Corp. III Life Sciences's key competitors include Hims & Hers Health, Inc., Alvotech, Inflection Point Acquisition Corp. V Class A Ordinary Shares, and others. These companies compete in similar markets and product categories.

Who does Oaktree Acquisition Corp. III Life Sciences partner with?

Oaktree Acquisition Corp. III Life Sciences's notable partners include Oaktree Capital Management.

Where is Oaktree Acquisition Corp. III Life Sciences headquartered?

Oaktree Acquisition Corp. III Life Sciences is headquartered in United States of America. It has been publicly traded since 2024.

Oaktree Acquisition Corp. III Life Sciences

OACC

Market cap

$263.04M+2.0%

Table of contents

Competitors

By market cap

Hims & Hers Health$8.0B-13.4%

Alvotech$1.2B-55.8%

IAC

Idea Acquisition Corp. $433.6M—

ITH

ITHAX Acquisition Corp III $306.1M—

OAC

Oaktree Acquisition Corp. III Life Sciences$263.0M+2.0%

DAA

Digital Asset Acquisition Corp. Class A Ordinary shares$238.7M-1.1%

YCY

AA Mission Acquisition Corporation II $149.7M—

IPE

Inflection Point Acquisition Corp. V Class A Ordinary Shares$125.2M—

Profile

Oaktree Acquisition Corp. III Life Sciences is a blank check company, also known as a Special Purpose Acquisition Company (SPAC), formed for the purpose of effecting a merger or similar business combination. The company leverages the global investment platform of Oaktree Capital Management to identify and acquire high-potential businesses within the healthcare and life sciences sectors. Its core value proposition lies in its management team's extensive experience in biopharmaceuticals, medical devices, and specialized healthcare services to drive long-term value creation in the public markets.

Competitive position

The company is an affiliate of Oaktree, a leading global investment firm with a significant track record in healthcare de-SPAC transactions.

GeographiesNorth America, United Kingdom, Europe

Customer segmentsInstitutional investors, Retail investors

Business modelSPAC, Acquisition-led growth

SuppliersSponsor capital, Investment banking services, Legal and accounting advisory

CustomersTarget private companies in healthcare, Public equity market investors

CountryUnited States of America

Listed2024

CEOZaid Pardesi

Websiteoaktreeacquisitioncorp.com

FilingsSEC EDGAR

Questions, answered.

What is Oaktree Acquisition Corp. III Life Sciences's market cap?: Oaktree Acquisition Corp. III Life Sciences (OACC) has a market capitalization of $263.0M and trades on XNAS.
Who are Oaktree Acquisition Corp. III Life Sciences's competitors?: Oaktree Acquisition Corp. III Life Sciences's key competitors include Hims & Hers Health, Inc., Alvotech, Inflection Point Acquisition Corp. V Class A Ordinary Shares, and others. These companies compete in similar markets and product categories.
Who does Oaktree Acquisition Corp. III Life Sciences partner with?: Oaktree Acquisition Corp. III Life Sciences's notable partners include Oaktree Capital Management.
Where is Oaktree Acquisition Corp. III Life Sciences headquartered?: Oaktree Acquisition Corp. III Life Sciences is headquartered in United States of America. It has been publicly traded since 2024.